skip to main content

Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

Siebert, U ; Sroczynski, G ; Rossol, S ; Wasem, J ; Ravens-Sieberer, U ; Kurth, B M ; Manns, M P ; McHutchison, J G ; Wong, J B

Gut, 2003-03, Vol.52 (3), p.425 [Peer Reviewed Journal]

Full text available

View all versions
Citations Cited by

Searching Remote Databases, Please Wait